neurokinin-receptor antagonists

Last updated on: 14.12.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

LiteratureThis section has been translated automatically.

  1. Couture R, Laneuville L, Guimond C et al (1989). Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn-Schmiedeberg's Archives of Pharmacology 340:547-557.
  2. Garcia-Recio S, Gascón P (2015). Biological and Pharmacological Aspects of the NK1-Receptor. Biomed Res Int. 2015;2015:495704. doi/10.1155/2015/495704
  3. Karthaus M, Schiel X, Ruhlmann C. H et al (2019). Neurokinin-1 receptor antagonists: review of their role for the prevention of chemotherapy-induced nausea and vomiting in adults. Expert Review of Clinical Pharmacology, 12(7), 661-680. doi/10.1080/17512433.2019.1621162
  4. Lin KL, Shekar S, Crumbaker M (2025). Neurokinin-3 Receptor Antagonism for Refractory Hot Flashes in Men. N Engl J Med 392:202-203 DOI/10.1056/NEJMc2412361
  5. Pinkerton JV, Redick DL, Homewood LN, Kaunitz AM. (2023) Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms. J Clin Endocrinol Metab. 18;108(11):e1448-e1449. doi.org/10.1210/clinem/dgad209
  6. Sass, F, Ma, T, Ekberg JH et al. (2024).NK2R control of energy expenditure and feeding to treat metabolic diseases. Nature 635, 987-1000. doi.org/10.1038/s41586-024-08207-0
  7. Sun, W., Yang, F., Zhang, H. et al. (2023). Structural insights into neurokinin 3 receptor activation by endogenous and analog peptide agonists. Cell Discov 9, 66. doi.org/10.1038/s41421-023-00564-w
  8. Thor, D., Prömel, S. Beyond incretins: targeting neurokinin receptors for obesity treatment. Sig Transduct Target Ther 10, 21 (2025). doi.org/10.1038/s41392-024-02100
  9. Wiedmann C , Paasche A , Nietfeld J et al (2023). Activation of neurokinin-III receptors modulates human atrial TASK-1 currents. J Mol Cell Cardiol 184:26-36. DOI: 10.1016/j.yjmcc.2023.09.010

Last updated on: 14.12.2025